Rivernorth Capital Management’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

Rivernorth Capital Management’s Portfolio LVAC Stock Details LVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-54,009	Closed	-$563K	–	695
2023 Q1	$563K	Buy	+54,009	New	+$559K	0.03%	305

Rivernorth Capital Management's LVAC Position: Q2 2023 in Review

Rivernorth Capital Management sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q2 2023, closing a stake of 54,009 shares — an estimated $563K sold.

Rivernorth Capital Management first reported a position in LVAC in Q1 2023 and held it in 1 quarter. The position peaked at $563K in Q1 2023. 0 funds tracked by Wall St. Rank hold LVAC as of Q2 2023.

Rivernorth Capital Management reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Rivernorth Capital Management sold 54,009 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $563K.
Rivernorth Capital Management first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q1 2023 and held it in 1 quarter.
Rivernorth Capital Management's LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $563K in Q1 2023.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on Rivernorth Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.